Recent Insider Activity Suggests Potential Gains for Editas Medicine Inc (EDIT)

Editas Medicine Inc’s recent filing unveils that its SVP, Chief Financial Officer Parison Amy unloaded Company’s shares for reported $769.0 on Jun 03 ’25. In the deal valued at $1.72 per share,446 shares were sold. As a result of this transaction, Parison Amy now holds 17,506 shares worth roughly $50417.28.

Then, Burkly Linda sold 726 shares, generating $1,252 in total proceeds. Upon selling the shares at $1.72, the EVP, CHIEF SCIENTIFIC OFFICER now owns 69,519 shares.

Before that, O’Neill Gilmore Neil sold 15,192 shares. Editas Medicine Inc shares valued at $26,196 were divested by the CEO at a price of $1.72 per share. As a result of the transaction, O’Neill Gilmore Neil now holds 280,282 shares, worth roughly $0.81 million.

H.C. Wainwright initiated its Editas Medicine Inc [EDIT] rating to a Buy in a research note published on April 28, 2025; the price target was $3. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid December from “a Neutral” to “an Underweight”. Truist also remained covering EDIT and has decreased its forecast on December 13, 2024 with a “Hold” recommendation from previously “Buy” rating. Stifel revised its rating on December 13, 2024. It rated EDIT as “a Hold” which previously was an “a Buy”.

Price Performance Review of EDIT

On Friday, Editas Medicine Inc [NASDAQ:EDIT] saw its stock fall -5.88% to $2.88. Over the last five days, the stock has gained 12.06%. Editas Medicine Inc shares have fallen nearly -41.34% since the year began. Nevertheless, the stocks have risen 126.77% over the past one year. While a 52-week high of $6.05 was reached on 02/19/25, a 52-week low of $0.91 was recorded on 04/07/25.

Levels Of Support And Resistance For EDIT Stock

The 24-hour chart illustrates a support level at 2.76, which if violated will result in even more drops to 2.63. On the upside, there is a resistance level at 3.05. A further resistance level may holdings at 3.21.

How much short interest is there in Editas Medicine Inc?

A steep rise in short interest was recorded in Editas Medicine Inc stocks on 2025-06-13, dropping by -0.67 million shares to a total of 8.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 9.09 million shares. There was a decline of -7.9%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.